Cargando…

Pathophysiology of Type 2 Diabetes in Children and Adolescents

Background: The prevalence of type 2 diabetes (DM) in children is disturbingly increasing in parallel with the increasing childhood obesity. Better knowledge regarding the pathophysiology of type 2 DM in children is paramount to devise an effective management plan. Objective: Discuss the pathophysio...

Descripción completa

Detalles Bibliográficos
Autores principales: Valaiyapathi, Badhma, Gower, Barbara, Ashraf, Ambika P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516333/
https://www.ncbi.nlm.nih.gov/pubmed/29879890
http://dx.doi.org/10.2174/1573399814666180608074510
_version_ 1783586985713074176
author Valaiyapathi, Badhma
Gower, Barbara
Ashraf, Ambika P.
author_facet Valaiyapathi, Badhma
Gower, Barbara
Ashraf, Ambika P.
author_sort Valaiyapathi, Badhma
collection PubMed
description Background: The prevalence of type 2 diabetes (DM) in children is disturbingly increasing in parallel with the increasing childhood obesity. Better knowledge regarding the pathophysiology of type 2 DM in children is paramount to devise an effective management plan. Objective: Discuss the pathophysiology of type 2 DM in children and adolescents. Methods and Results: This is a comprehensive review of the literature on this topic. Type 2 DM in childhood is viewed as a continuum of insulin resistance (IR) which is determined by an underlying genetic predisposition, intrauterine environment, excessive food consumption, continued rapid weight gain, and poor lifestyle. Besides IR, this is compounded by multiple metabolic defects including β-cell dysfunction and inadequate insulin secretion, α-cell dysfunction, hyperglucagonemia and increased hepatic glucose production, lipotoxicity, inflammation, deficiencies in incretin production and action, and increased renal glucose reabsorption. The confluence of genetic and environmental factors underscores the complexity in disease progression. Conclusion: A consistent single risk factor for type 2 DM is obesity and related IR and therefore it is essential to curtail the progression of obesity. It is important to investigate the role of stringent dietary and nutritional approaches, medications that enhance β-cell function and insulin sensitivity.
format Online
Article
Text
id pubmed-7516333
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-75163332020-10-15 Pathophysiology of Type 2 Diabetes in Children and Adolescents Valaiyapathi, Badhma Gower, Barbara Ashraf, Ambika P. Curr Diabetes Rev Diabetes Background: The prevalence of type 2 diabetes (DM) in children is disturbingly increasing in parallel with the increasing childhood obesity. Better knowledge regarding the pathophysiology of type 2 DM in children is paramount to devise an effective management plan. Objective: Discuss the pathophysiology of type 2 DM in children and adolescents. Methods and Results: This is a comprehensive review of the literature on this topic. Type 2 DM in childhood is viewed as a continuum of insulin resistance (IR) which is determined by an underlying genetic predisposition, intrauterine environment, excessive food consumption, continued rapid weight gain, and poor lifestyle. Besides IR, this is compounded by multiple metabolic defects including β-cell dysfunction and inadequate insulin secretion, α-cell dysfunction, hyperglucagonemia and increased hepatic glucose production, lipotoxicity, inflammation, deficiencies in incretin production and action, and increased renal glucose reabsorption. The confluence of genetic and environmental factors underscores the complexity in disease progression. Conclusion: A consistent single risk factor for type 2 DM is obesity and related IR and therefore it is essential to curtail the progression of obesity. It is important to investigate the role of stringent dietary and nutritional approaches, medications that enhance β-cell function and insulin sensitivity. Bentham Science Publishers 2020-04 2020-04 /pmc/articles/PMC7516333/ /pubmed/29879890 http://dx.doi.org/10.2174/1573399814666180608074510 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Diabetes
Valaiyapathi, Badhma
Gower, Barbara
Ashraf, Ambika P.
Pathophysiology of Type 2 Diabetes in Children and Adolescents
title Pathophysiology of Type 2 Diabetes in Children and Adolescents
title_full Pathophysiology of Type 2 Diabetes in Children and Adolescents
title_fullStr Pathophysiology of Type 2 Diabetes in Children and Adolescents
title_full_unstemmed Pathophysiology of Type 2 Diabetes in Children and Adolescents
title_short Pathophysiology of Type 2 Diabetes in Children and Adolescents
title_sort pathophysiology of type 2 diabetes in children and adolescents
topic Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516333/
https://www.ncbi.nlm.nih.gov/pubmed/29879890
http://dx.doi.org/10.2174/1573399814666180608074510
work_keys_str_mv AT valaiyapathibadhma pathophysiologyoftype2diabetesinchildrenandadolescents
AT gowerbarbara pathophysiologyoftype2diabetesinchildrenandadolescents
AT ashrafambikap pathophysiologyoftype2diabetesinchildrenandadolescents